Lilly Celebrates 17th Consecutive Year as One of Working Mother 100 Best Companies

INDIANAPOLIS, Sept. 16, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has once again been selected one of the "100 Best Companies" by Working Mother magazine. This is the 17th consecutive year for this honor.

In its 26th year, the Working Mother 100 Best Companies initiative selects the nation's top companies for family-friendly benefits. One hundred percent of this year's winning companies offer flex-time hours, telecommuting, paid maternity leave and employee assistance programs, according to the magazine.

Lilly has an extensive record of creating a working environment that empowers employees to balance professional and personal life responsibilities. Benefit-related programs include on-site child care, resources and referrals, on-site summer camp, back-up care, adoption assistance, support groups, on-site conveniences, health services, nursing mother stations and support and development programs for field-based female employees.

Companies were selected for the honor based on an extensive application with more than 650 questions, including data on the access and usage of flexible work arrangements, parental leave, childcare, health and wellness support and the advancement of women to all levels of management.

Lilly will be celebrated at this year's Working Mother 100 Best Companies WorkLife Congress Oct. 18-20, in New York City.

The 100 Best Companies, as well as national comparisons, are profiled in the October issue of Working Mother and at workingmother.com/bestcompanies.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com. C-LLY

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )

SOURCE Eli Lilly and Company

Suggested Articles

While the failure might be a missed chance at revenue, it shouldn’t hurt Ibrance’s ability to rack up sales in the metastatic setting, one exec says.

Patients receiving Bavencio actually did worse than those who got placebo, increasing the risk of death by 31%.

Seattle Genetics and Astellas’ newcomer Padcev now has what every cancer drugmaker is looking for: Randomized trial data showing it can extend lives.